注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Aeterna Zentaris Inc是一家從事商業化開發治療和診斷測試的專業生物製藥公司。該公司的主導產品Macrilen (macimorelin)是一種用於診斷成人生長激素缺乏症(AGHD)患者的口服試驗。 Macrilen (macimorelin)是一種口服可用的擬肽ghrelin受體激動劑,通過與ghrelin受體(GHSR-1a)結合來刺激生長激素的分泌,並在內分泌學和腫瘤學適應症中都有應用。該公司還利用macimorelin的臨床和令人信服的安全性來開髮用於診斷兒童期生長激素缺乏症 (CGHD) 的產品。它還在開發針對SARS-CoV-2(導致COVID-19的病毒)和沙眼衣原體的口服預防性細菌疫苗。該公司專注於馬西莫林在亞洲和世界其他地區的商業化。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Dennis Turpin | - | 1999 | Independent Director |
Ulf R. Rapp | - | - | Member of the Scientific Advisory Board |
Marcel Verheij | - | - | Member of the Scientific Advisory Board |
Gerald Batist | - | - | Member of the Scientific Advisory Board |
Gilles R. Gagnon | 70 | 2007 | Independent Director |
Hartmut Michel | - | - | Member of the Scientific Advisory Board |
Alan H. DeCherney | - | - | Member of the Scientific Advisory Board |
Frans M. J. Debruyne | - | - | Member of the Scientific Advisory Board |
Peter G. Edwards | 63 | 2020 | Independent Director |
Klaus Paulini | - | 2019 | President, CEO & Executive Director |
Daniel Douglas Von Hoff | 76 | 2005 | Member of the Scientific Advisory Board |
Klaus H. R. Diedrich | - | - | Member of the Scientific Advisory Board |
René Frydman | - | - | Member of the Scientific Advisory Board |
Carolyn S. Egbert | - | 2012 | Independent Chair of the Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核